The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Sublethal Concentrations of Pleurocidin-Derived Antimicrobial Peptides Inhibit Macromolecular Synthesis in Escherichia coli
Open accessAbstract
Cationic bactericidal peptides are components of natural host defenses against infections. While the mode of antibacterial action of cationic peptides remains controversial, several targets, including the cytoplasmic membrane and macromolecular synthesis, have been identified for peptides acting at high concentrations. The present study identified peptide effects at lower, near-lethal inhibitory concentrations. An amidated hybrid of the flounder pleurocidin and the frog dermaseptin (P-Der), two other pleurocidin derivatives, and pleurocidin itself were studied. At 2 μg/ml, the MIC, P-Der inhibited Escherichia coli growth in a broth dilution assay but did not cause bacterial death within 30 min, as estimated by viable count analysis. Consistent with this, P-Der demonstrated a weak ability to permeabilize membranes but was able to translocate across the lipid bilayer of unilamellar liposomes. Doses of 20 μg/ml or more reduced bacterial viable counts by about 2 log orders of magnitude within 5 min after peptide treatment. Abrupt loss of cell membrane potential, observed with a fluorescent dye, dipropylthiacarbocyanine, paralleled bacterial death but did not occur at the sublethal, inhibitory concentrations. Both lethal and sublethal concentrations of P-Der affected macromolecular synthesis within 5 min, as demonstrated by incorporation of [ 3 H]thymidine, [ 3 H]uridine, and [ 3 H]histidine, but the effects were qualitatively distinct at the two concentrations. Variations of the inhibition pattern described above were observed for pleurocidin and two other derivatives. Our results indicate that peptides at their lowest inhibitory concentrations may be less capable of damaging cell membranes, while they maintain their ability to inhibit macromolecular synthesis. Better understanding of the effects of peptides acting at their MICs will contribute to the design of new peptides effective at lower, less toxic concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Self-citationHancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Self-citationSims, P. J., Waggoner, A. S., Wang, C.-H., & Hoffman, J. F. (1974) · Biochemistry · doi:10.1021/bi00713a022 · Cited by 951
Park, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Action of Antimicrobial Peptides: Two-State Model
Huang, H. W. (2000) · Biochemistry · doi:10.1021/bi000946l · Cited by 740
Wu, M., Maier, E., Benz, R., & Hancock, R. E. W. (1999) · Biochemistry · doi:10.1021/bi9826299 · Cited by 736
Self-citationMatsuzaki, K., Murase, O., Fujii, N., & Miyajima, K. (1996) · Biochemistry · doi:10.1021/bi960016v · Cited by 723
Boman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Cole, A. M., Weis, P., & Diamond, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12008 · Cited by 541
Susceptibility testing of antimicrobials in liquid media
Amsterdam, D. (1996) · Medical Entomology and Zoology · Cited by 492
Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., & Otvos, L. (2001) · Biochemistry · doi:10.1021/bi002656a · Cited by 491
Loh, B., Grant, C., & Hancock, R. E. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.4.546 · Cited by 481
Self-citationMechanism of antimicrobial action of indolicidin
Subbalakshmi, C. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00008-1 · Cited by 474
Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria
Friedrich, C. L., Moyles, D., Beveridge, T. J., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2086-2092.2000 · Cited by 464
Self-citationInteraction of Cationic Antimicrobial Peptides with Model Membranes
Zhang, L., Rozek, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104925200 · Cited by 410
Self-citationInteraction between Heat Shock Proteins and Antimicrobial Peptides
Otvos, O, I., Rogers, M. E., Consolvo, P. J., Condie, B. A., Lovas, S., Bulet, P., & Blaszczyk-Thurin, M. (2000) · Biochemistry · doi:10.1021/bi0012843 · Cited by 370
Mor, A., Huong, N. V., Delfour, A., Migliore-Samour, D., & Nicolas, P. (1991) · Biochemistry · doi:10.1021/bi00100a014 · Cited by 313
Matsuzaki, K., Murase, O., Fujii, N., & Miyajima, K. (1995) · Biochemistry · doi:10.1021/bi00019a033 · Cited by 308
Molecular recognition between membrane-spanning polypeptides
Shai, Y. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89101-x · Cited by 280
Moore, R. A., Bates, N. C., & Hancock, R. E. W. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.3.496 · Cited by 237
Self-citationFriedrich, C. L., Rozek, A., Patrzykat, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009691200 · Cited by 225
Self-citationKobayashi, S., Takeshima, K., Park, C. B., Kim, S. C., & Matsuzaki, K. (2000) · Biochemistry · doi:10.1021/bi0004549 · Cited by 213
Cole, A. M., Darouiche, R. O., Legarda, D., Connell, N., & Diamond, G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2039-2045.2000 · Cited by 161
Stages of Polymyxin B Interaction with the Escherichia coli Cell Envelope
Daugelavičius, R., Bakienė, E., & Bamford, D. H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2969-2978.2000 · Cited by 154
Castle, M., Nazarian, A., Yi, S. S., & Tempst, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32555 · Cited by 141
Douglas, S. E., Gallant, J. W., Gong, Z., & Hew, C. S. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(00)00052-5 · Cited by 110
Pellegrini, A., Thomas, U., Wild, P., Schraner, E. M., & von Fellenberg, R. (2000) · Microbiological Research · doi:10.1016/s0944-5013(00)80040-3 · Cited by 80
Yoshida, K., Mukai, Y., Niidome, T., Higuchi, C. T., Tokunaga, Y., Hatakeyama, T., & Aoyagi, H. (2001) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2001.00802.x · Cited by 72
Cited by
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Self-citationThe relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Self-citationCationic host defense (antimicrobial) peptides
Brown, K. L., & Hancock, R. E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.004 · Cited by 839
Self-citationAntimicrobial peptides: key components of the innate immune system
Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2012) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2011.594423 · Cited by 799
Metadata
- Authors
- Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V., & Hancock, R. E. W.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-03
- Volume
- 46
- Issue
- 3
- Pages
- 605-614
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2096559689
- Cited by
- 354
- References
- 30
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.